Expanding Medicare Advantage for patients with end-stage renal disease
Official title: Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
Funded at Brown University · NIH-10795031 · Data updated 2026-11-12
This study looks at how letting people with end-stage kidney disease join Medicare Advantage plans can help them get better healthcare and improve their health, especially for those in underserved communities.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | June 21, 2021 |
| Project end | February 28, 2026 |
| Funding year | 2024 |
| Award (this year) | $520,578 |
| NIH project number | 5R01DK129388-04 |
| Project ID | NIH-10795031 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with end-stage renal disease who are eligible for Medicare.
✕Less likely to help
Patients who do not have end-stage renal disease or those who are not eligible for Medicare may not benefit from this research.
What this research studies
This research investigates the impact of allowing patients with end-stage renal disease (ESRD) to enroll in Medicare Advantage plans, which could improve their access to healthcare. It focuses on understanding how this policy change affects health outcomes, hospitalizations, and disparities in care among disadvantaged communities. The study will analyze data on ESRD patients to evaluate the effectiveness of these plans and their implications for health equity. By examining the experiences of patients who transition to these plans, the research aims to provide valuable insights for policymakers.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare access and outcomes for patients with end-stage renal disease.
How similar studies have gone: Previous research has shown that policy changes in Medicare coverage can significantly impact health outcomes for patients with chronic conditions, suggesting potential success for this approach.
Where this research is happening
-
Brown University
Providence, United States Active
Researchers
- Principal investigator: Trivedi, Amal N. — Brown University
- Study coordinator: Trivedi, Amal N.
Related research
Other NIH-funded projects on the same topics.
-
How life circumstances affect brain aging in people with end-stage kidney disease
This project looks at how neighborhood, income, education, and personal resilience relate to earlier memory and thinking problems in adults with end-stage kidney disease.
-
How life circumstances affect memory and thinking in people with end-stage kidney disease
Researchers will look at how social and economic factors relate to memory and thinking problems across adults with end-stage kidney disease.
-
How long the shingles (zoster) vaccine protects people with kidney failure, before and after transplant
This project checks how long the shingles vaccine protects adults with end-stage kidney disease who are waiting for or have received a kidney transplant.
-
Activating a cell protein to prevent early dialysis fistula failure
This research tests a drug-like activator of the Mac-1 protein to reduce inflammation and help new dialysis fistulas work better for people with end-stage kidney disease.
-
Pain care for veterans with end-stage kidney disease
This project looks at how changes in VA opioid policies have affected pain control and safety for veterans with end-stage kidney disease.
-
How systemic racism affects cognitive aging in patients with end-stage renal disease
This study is looking at how racism affects brain health in Black patients with severe kidney disease, aiming to understand why some people experience faster cognitive decline and how others manage to stay resilient, so we can find better ways to support their health.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.